Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating continuous subcutaneous lenalidomide in patients with multiple myeloma, focusing on safety, efficacy, and pharmacokinet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Starton Therapeutics, Inc | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING